BioSpace News Archive

Drug Development

Six Biotechs Launch IPO Plans in Last Days of May, While Iterum Therapeutics Adjusts IPO Goals

It’s been a busy month for IPOs. Numerous biotech companies announced their intentions to publicly list their stock on an exchange in the U.S. or abroad in order to gain new funding to advance developmental programs.

May 28, 2018
·
6 min read
·
Alex Keown
FDA

FDA Action Alert: TherapeuticsMD and Kitov Pharmaceuticals

The Memorial Day Holiday is making the U.S. Food and Drug Administration (FDA)’s schedule a bit more complicated. Here’s a look at two more FDA decisions coming up this week.

May 28, 2018
·
2 min read
·
Mark Terry
Business

Biotech Leadership Transformations: Week of May 21

There have been a number of leadership changes in the life sciences industries over the past week. BioSpace compiled a roundup of the changing landscape of the c-suite and boards of directors across the industry.

May 28, 2018
·
4 min read
·
Alex Keown
Business

10 Women Biotech CEOs Lead the Charge

The general consensus is that only about seven to nine percent of chief executive roles in biotech are filled by women. As low as that sounds, it’s better than in the Fortune 500, where only about 4.2 percent are led by female chief executives.

May 28, 2018
·
4 min read
·
Mark Terry